Harrow
2 followers
‌
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical pro... Read more
Industries
Headquarters
Employees
Links
Org chart
Mark L. Baum
Founder, Chairman, And CEO Of Harrow, Inc.
Mark L. Baum
Collapse
John P. Saharek
Chief Commercial Officer (cco)
Andrew R. Boll
Founder, Chief Financial Officer And Corporate Secretary
Dennis E. Saadeh
Chief Scientific Officer
Kim Barratt
Chief Talent Officer
Mark Mannebach
Head of Regulatory Affairs & Pharmacovigilance
Garrett S.
Director Of Information Technology
